The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Hepatocellular Carcinoma: Hepatocyte-selective Enhancement at Gadoxetic Acid–enhanced MR Imaging—Correlation with Expression of Sinusoidal and Canalicular Transporters and Bile Accumulation
Abstract
PURPOSE: To investigate the mechanism of enhancement of hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced hepatobiliary phase magnetic resonance (MR) images and to characterize HCC thus enhanced. MATERIALS AND METHODS: This retrospective study was approved by the institutional review board, and patient informed consent for research use of the resected specimen was obtained. MR images in 25 patients (20 men, five women; mean age, 68 years; range, 49-82 years) with 27 resected hypervascular HCCs (one well, 13 moderately, 13 poorly differentiated) that demonstrated hepatocyte-selective enhancement on gadoxetic acid-enhanced MR images, were quantitatively studied, and findings were correlated with results of immunohistochemical staining for a sinusoidal transporter, organic anion transporting polypeptide (OATP) 1B1 (OATP1B1) and/or OATP1B3 (OATP1B1 and/or -1B3), and a canalicular transporter, multidrug resistance-associated protein 2 (MRP2), and also with bile accumulation in tumors. Statistical analysis was performed with the Student t test and Scheffé post hoc test. RESULTS: Combined with positive OATP1B1 and/or -1B3 expression (O+), two patterns of MRP2 expression contributed to high enhancement: decreased expression (M-, n = 3) and increased expression at the luminal membrane of pseudoglands (M+[P], n = 3). Nodules without OATP1B1 and/or -1B3 expression (O-, n = 13) and nodules with O+ associated with increased MRP2 expression only at the canaliculi (M+[C], n = 8) induced significantly lower enhancement than those with the two expression patterns described before (O+/M- group vs O- group, P = .002; O+/M- group vs O+/M+[C] group, P = .047; O+/M+[P] group vs O- group, P < .001; O+/M+[P] group vs O+/M+[C] group, P < .001). Nodules with bile pigment (n = 12) showed significantly higher enhancement (P = .004); all five nodules (one well differentiated HCC, four moderately differentiated HCCs), which were enhanced more than adjacent liver parenchyma, contained bile pigment. CONCLUSION: High hepatocyte-selective enhancement is induced by expression patterns of transporters, which may result in accumulation of gadoxetic acid in cytoplasm of tumor cells or in lumina of pseudoglands. An HCC with gadoxetic acid enhancement is characterized by bile accumulation in tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Edmondson, H. A., & Steiner, P. E. (1954) · Cancer · doi:10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e · Cited by 2,772
The general rules for the clinical and pathological study of primary liver cancer
Liver Cancer Study Group of Japan (1989) · The Japanese Journal of Surgery · doi:10.1007/bf02471576 · Cited by 1,037
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g156 · Cited by 620
Hamm, B., Staks, T., Mühler, A., Bollow, M., Taupitz, M., Frenzel, T., Wolf, K. J., Weinmann, H. J., & Lange, L. (1995) · Radiology · doi:10.1148/radiology.195.3.7754011 · Cited by 575
Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001448200 · Cited by 522
Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6
Cui, Y., König, J., Leier, I., Buchholz, U., & Keppler, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004968200 · Cited by 515
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl, T. J., Kümmel, S., Hammerstingl, R., Schellenbeck, M., Schumacher, G., Balzer, T., Schwarz, W., Müller, P. K., Bechstein, W. O., Mack, M. G., et al. (1996) · Radiology · doi:10.1148/radiology.200.1.8657946 · Cited by 453
MacSween's Pathology of the Liver
(2012) · Elsevier eBooks · doi:10.1016/c2009-0-47964-9 · Cited by 420
Huppertz, A., Balzer, T., Blakeborough, A., Breuer, J., Giovagnoni, A., Heinz-Peer, G., Laniado, M., Manfredi, R. M., Mathieu, D. G., Mueller, D., et al. (2004) · Radiology · doi:10.1148/radiol.2301020269 · Cited by 396
Huppertz, A., Haraida, S., Kraus, A., Zech, C. J., Scheidler, J., Breuer, J., Helmberger, T. K., & Reiser, M. F. (2005) · Radiology · doi:10.1148/radiol.2342040278 · Cited by 370
Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma
Narita, M., Hatano, E., Arizono, S., Miyagawa-Hayashino, A., Isoda, H., Kitamura, K., Taura, K., Yasuchika, K., Nitta, T., Ikai, I., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0056-4 · Cited by 348
Kim, S. H., Kim, S. H., Lee, J., Kim, M. J., Jeon, Y. H., Park, Y., Choi, D., Lee, W. J., & Lim, H. K. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.08.1262 · Cited by 311
Hepatobiliary transporters and drug‐induced cholestasis†
Pauli‐Magnus, C., & Meier, P. J. (2006) · Hepatology · doi:10.1002/hep.21359 · Cited by 285
Zech, C. J., Grazioli, L., Breuer, J., Reiser, M. F., & Schoenberg, S. O. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181705cd1 · Cited by 227
Imai, Y., Murakami, T., Yoshida, S., Nishikawa, M., Ohsawa, M., Tokunaga, K., Murata, M., Shibata, K., Zushi, S., Kurokawa, M., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.9113 · Cited by 223
Self-citationBluemke, D. A., Sahani, D., Amendola, M., Balzer, T., Breuer, J., Brown, J. J., Casalino, D. D., Davis, P. L., Francis, I. R., Krinsky, G., et al. (2005) · Radiology · doi:10.1148/radiol.2371031842 · Cited by 223
van Montfoort, J. E., Stieger, B., Meijer, D. K. F., Weinmann, H.-J., Meier, P. J., & Fattinger, K. E. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34879-7 · Cited by 223
Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma
Nies, A. T., König, J., Pfannschmidt, M., Klar, E., Hofmann, W. J., & Keppler, D. (2001) · International Journal of Cancer · doi:10.1002/ijc.1498 · Cited by 189
Kamisako, T., Leier, I., Cui, Y., König, J., Buchholz, U., Hummel-Eisenbeiss, J., & Keppler, D. (1999) · Hepatology · doi:10.1002/hep.510300220 · Cited by 184
Ueda, K., Terada, T., Nakanuma, Y., & Matsui, O. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90316-u · Cited by 162
Hepatobiliary transporter expression in human hepatocellular carcinoma
Zollner, G., Wagner, M., Fickert, P., Silbert, D., Fuchsbichler, A., Zatloukal, K., Denk, H., & Trauner, M. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01033.x · Cited by 158
Cui, Y., König, J., Nies, A. T., Pfannschmidt, M., Hergt, M., Franke, W. W., Alt, W., Moll, R., & KEPPLER, D. O. R. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000065015.02412.48 · Cited by 116
Vavricka, S. R., Jung, D., Fried, M., Grützner, U., Meier, P. J., & Kullak-Ublick, G. A. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.10.008 · Cited by 112
Bartolozzi, C., Crocetti, L., Lencioni, R. A., Cioni, D., Pina, C. D., & Campani, D. (2007) · European Radiology · doi:10.1007/s00330-007-0602-5 · Cited by 94
Borght, S. V., Libbrecht, L. J., Blokzijl, H., Faber, K. N., Moshage, H. J., Aerts, R., Steenbergen, W. V., Jansen, P. L. M., Desmet, V. J., & Roskams, T. (2005) · The Journal of Pathology · doi:10.1002/path.1852 · Cited by 79
Pascolo, L., Petrović, S., Cupelli, F., Bruschi, C. V., Anelli, P. L., Lorusso, V., Visigalli, M., Uggeri, F., & Tiribelli, C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4318 · Cited by 62
Fujita, M., Yamamoto, R., Fritz‐Zieroth, B., Yamanaka, T., Takahashi, M., Miyazawa, T., Tatsuta, M., Terada, N., Hosomi, N., Inoue, E., et al. (1996) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880060310 · Cited by 39
Cited by
Choi, J.-Y., Lee, J.-M., & Sirlin, C. B. (2014) · Radiology · doi:10.1148/radiol.14132361 · Cited by 513
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
Roberts, L. R., Sirlin, C. B., Zaiem, F., Almasri, J., Prokop, L. J., Heimbach, J. K., Murad, M. H., & Mohammed, K. (2018) · Hepatology · doi:10.1002/hep.29487 · Cited by 497
Primovist, Eovist: What to expect?
Van Beers, B. E., Pastor, C. M., & Hussain, H. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.031 · Cited by 407
Bile acid transporters and regulatory nuclear receptors in the liver and beyond
Halilbasic, E., Claudel, T., & Trauner, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.002 · Cited by 393
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
Sano, K., Ichikawa, T., Motosugi, U., Sou, H., Muhi, A. M., Matsuda, M., Nakano, M., Sakamoto, M., Nakazawa, T., Asakawa, M., et al. (2011) · Radiology · doi:10.1148/radiol.11101840 · Cited by 353
Metadata
- Authors
- Tsuboyama, T., Onishi, H., Kim, T., Akita, H., Hori, M., Tatsumi, M., Nakamoto, A., Nagano, H., Matsuura, N., Wakasa, K., & Tomoda, K.
- Venue
- Radiology
- Published
- 2010-06
- Volume
- 255
- Issue
- 3
- Pages
- 824-833
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2004585555
- Cited by
- 266
- References
- 28
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.